Cargando…

Impact of Season and Other Factors on Initiation, Discontinuation, and Switching of Systemic Drug Therapy in Patients with Psoriasis: A Retrospective Study

This study investigated whether systemic drug prescribing for psoriasis varies by season and other exacerbating factors. Eligible patients with psoriasis were assessed for each season for initiation, discontinuation, and switching of systemic drugs. A total of 360,787 patients were at risk of initia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Huifang, Kirk, Brenna, Polinski, Jennifer M., Yue, Xiaomeng, Kilpatrick, Ryan D., Gelfand, Joel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982330/ https://www.ncbi.nlm.nih.gov/pubmed/36876219 http://dx.doi.org/10.1016/j.xjidi.2022.100171

Ejemplares similares

Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USA
por: Pilon, Dominic, et al.
Publicado: (2022)

Hidden dynamics: the mathematics of switches, decisions and other discontinuous behaviour
por: Jeffrey, Mike R
Publicado: (2018)

Erythrodermic psoriasis after discontinuation of ixekizumab
por: Potter, Kathryn Anne, et al.
Publicado: (2017)

Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands
por: Morales, Daniel R., et al.
Publicado: (2020)

Puvatherapy for Psoriasis and Other Skin Diseases—An Initial Report
por: Lavery, Hilary A., et al.
Publicado: (1980)

Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3
por: Ogdie, Alexis, et al.
Publicado: (2015)

Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study
por: Winter, Max-Paul, et al.
Publicado: (2019)

Persistence, Discontinuation, and Switching Patterns of Newly Initiated TNF Inhibitor Therapy in Ankylosing Spondylitis Patients in the United States
por: Hunter, Theresa, et al.
Publicado: (2019)

Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
por: Kim, Byungsoo, et al.
Publicado: (2019)

High density lipoprotein cholesterol function improves after successful treatment of psoriasis: a step forward in the right direction
por: Mehta, Nehal N., et al.
Publicado: (2014)

Women’s contraceptive discontinuation and switching behavior in urban Senegal, 2010–2015
por: Barden-O’Fallon, Janine, et al.
Publicado: (2018)

Assessing regional differences in contraceptive discontinuation, failure and switching in Brazil
por: Leite, Iúri C, et al.
Publicado: (2007)

Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review
por: Masson Regnault, Marie, et al.
Publicado: (2022)

Dermatofibrosarcoma protuberans (DFSP) with fibrosarcomatous changes in a patient with psoriasis treated with adalimumab
por: Belyaeva, Elizaveta A., et al.
Publicado: (2015)

The order of vasopressor discontinuation and incidence of hypotension: a retrospective cohort analysis
por: Song, Xuan, et al.
Publicado: (2021)

Seasonal Variation of Psoriasis and Its Impact in the Therapeutic Management: A Retrospective Study on Chinese Patients
por: Zheng, Xuanwei, et al.
Publicado: (2021)

Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries
por: Yun, Huifeng, et al.
Publicado: (2014)

Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors
por: Schmidt, Lana, et al.
Publicado: (2023)

Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab
por: van der Schoot, Lara S., et al.
Publicado: (2022)

Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study
por: Wan, Joy, et al.
Publicado: (2013)

Contraceptive Adoption, Discontinuation, and Switching among Postpartum Women in Nairobi's Urban Slums
por: Mumah, Joyce N., et al.
Publicado: (2015)

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis
por: Driver, C. Noelle, et al.
Publicado: (2023)

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
por: Fitzgerald, Timothy, et al.
Publicado: (2021)

Cerebellum encodes and influences the initiation, performance, and termination of discontinuous movements in mice
por: Gaffield, Michael A, et al.
Publicado: (2022)

Psoriasis in the U.S. Medicare population: prevalence, treatment, and factors associated with biologic use
por: Takeshita, Junko, et al.
Publicado: (2015)

Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
por: Georgakopoulos, Jorge R., et al.
Publicado: (2020)

Seasonal variation in hemodialysis initiation: A single-center retrospective analysis
por: Maeoka, Yujiro, et al.
Publicado: (2017)

The patient perspective on vaccine uptake in adults with psoriasis and eczema
por: Noe, Megan H., et al.
Publicado: (2023)

Biological therapy utilization, switching, and cost among patients with psoriasis: retrospective analysis of administrative databases in Southern Italy
por: Guerriero, Francesca, et al.
Publicado: (2017)

Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting
por: Liang, Huifang, et al.
Publicado: (2019)

Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
por: LaFratte, Christopher, et al.
Publicado: (2023)

Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation
por: Hellfritzsch, Maja, et al.
Publicado: (2017)

Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network
por: Hillert, Jan, et al.
Publicado: (2021)

Suboptimal Discontinuous Current-Clamp Switching Rates Lead to Deceptive Mouse Neuronal Firing
por: Manuel, Marin
Publicado: (2021)

Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
por: Varma, Aakaash, et al.
Publicado: (2020)

Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab
por: Chiang, Cheng-Ying, et al.
Publicado: (2021)

Pathogenic role of S100 proteins in psoriasis
por: Liang, Huifang, et al.
Publicado: (2023)

IUD discontinuation rates, switching behavior, and user satisfaction: findings from a retrospective analysis of a mobile outreach service program in Pakistan
por: Azmat, Syed Khurram, et al.
Publicado: (2013)

Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema
por: Schechet, Sidney A, et al.
Publicado: (2019)

Accurate Inference of Subtle Population Structure (and Other Genetic Discontinuities) Using Principal Coordinates
por: Reeves, Patrick A., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bpeb0oialramh1lbj57idarlls